Status:
TERMINATED
Evaluation of Pulse Oximetry Sensors in Neonates
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborating Sponsors:
Medtronic - MITG
Conditions:
Premature Birth
Eligibility:
All Genders
Up to 2 years
Brief Summary
The purpose of this study is to evaluate sensor longevity and skin integrity with two different models of neonatal pulse oximetry sensors currently used for monitoring oxygen levels in small infants.
Detailed Description
A common method for assessing the respiratory status of hospitalized children is the use of pulse oximetry. This noninvasive device typically is placed on a finger, foot/palm of a child. Red and infra...
Eligibility Criteria
Inclusion
- Gestational age \< 34 weeks
- Weight \< 3.0 kg
- Postnatal age \< 2 weeks
- Anticipated pulse oximetry monitoring for at least 14 days
Exclusion
- Presence of any skin irritation or breakdown on either foot
- Foot impediments which would preclude proper placement of the test sensors
- Known allergies to adhesive materials
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00179972
Start Date
September 1 2005
End Date
May 1 2010
Last Update
July 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611